Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest
Stopped early · Phase 2
Conditions studied: Idiopathic Pulmonary Fibrosis, Hypoxemia
In brief
This is an open label study in which eligible IPF subjects who are using supplemental oxygen at rest will receive GBT440 orally daily.
Key facts
- Study ID
- NCT02989168
- Run by
- Global Blood Therapeutics
- People needed
- 14
- Starts
- 2016-11-01
- Expected to finish
- 2017-10-23
- Last updated by the study team
- 2020-08-21
Who can join
Age: 45 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Documented diagnosis of IPF.
- Receiving supplemental oxygen for use at rest.
- Weight ≥ 40 kg.
- Male or female of child bearing potential willing and able to use highly effective methods of contraception from study start to 30 days after the last dose of study drug.
You may not qualify if…
- FEV1/FVC < 70%
- History of other interstitial lung diseases.
- Subject plans to begin or has commenced pulmonary rehabilitation within 30 days of screening.
- Corticosteroid (> 10 mg per day of prednisone or an equivalent) administered for 7 days or longer, within 30 days of screening.
- Participated in another clinical trial of an investigational drug (or medical device) within 30 days or 5-half-lives, whichever is longer, prior to screening, or is currently participating in another trial of an investigational drug (or medical device).
- Female who is breast-feeding or pregnant
- Current smoker or history of smoking within 3 months from screening
Where it is running
- Study site — Birmingham, Alabama, United States
- Study site — Denver, Colorado, United States
- Study site — New Orleans, Louisiana, United States
- Study site — Philadelphia, Pennsylvania, United States
- Study site — Nashville, Tennessee, United States
- Study site — Salt Lake City, Utah, United States
- Study site — London, United Kingdom
- Study site — Manchester, United Kingdom
- Study site — Southampton, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.